Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04221464

Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)

The creation of a prospective clinical-biological base dedicated to peritoneal carcinosis must therefore be able to serve as a support for this essential search for transfer.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cancer Neoplasms Peritoneal Carcinosis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institut du cancer de Montpellier ICM

Montpellier, 34298, France

Location status: Recruiting

Location contact

QUENET François,MD

CONTACT

[email protected]

0467612354 ext. 33

About this study

The main objective is to improve the knowledge of carcinosis mechanisms to develop a specific treatment.

That's why this blood collection and tissue collection is very important for the future, these collection will be permitted to the scientists to develop a research specially for carcinosis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient over the age of 18;
  • Patient managed for peritoneal carcinosis : digestives origins (pancreatic, gastroesophageal junction, colorectal, bowel) or peritoneum cancer
  • Patient eligible for a peritoneal carcinosis treatment : at least one (or more) surgery (s) ;chemotherapy or any treatment for this disease
  • Patient agree will all study procedure : biological samples & tissues samples
  • Patient giving informed consent

Exclusion criteria

  • Patient not affiliated to Social Protection system
  • Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons
  • The level of French is insufficient to consent to the study and to response to the questionnaires
  • Patient under guardianship
  • Pregnancy ou breast-feeding women
  • Patient treated in case of an emergency

Treatment and study plan

Biological collection

Biological

Blood samples collected before any treatment (if chemotherapy for example), at every surgery, one month after surgery, at progression

Tissues collections

Other

Tumours and not tumours tissues will be collected before any treatment (if chemotherapy for example), at every surgery, one month after surgery, at progression

Primary outcomes

  1. Proportion of patients who gave their consent to participate in the study

    Time frame: Until the study completion: 4 years

    The proportion of patients who consent to participate in the study among the screened patients

Study contacts

Contact information is provided by the study sponsor or research team.

Aurore MOUSSION

CONTACT

[email protected]

467613100 ext. 33

Sponsors and collaborators

Lead sponsor

Institut du Cancer de Montpellier - Val d'Aurelle

Other

Registry information

Official study title

Development of a Clinical and Biological Database Monocentric and Prospective in Peritoneal Carcinosis

Acronym: BCB

Important dates

Study start
2019
Primary completion
2028
Study completion
2038
First posted
Jan 9, 2020
Registry last updated
Feb 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.